Stock Based Compensation - Schedule of Stock Option Activities (Details) - Previously Reported [Member] - $ / shares |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Dec. 31, 2024 |
Jun. 30, 2024 |
||||
| Schedule of Stock Option Activities [Line Items] | |||||
| Number of Shares, Beginning Balance | 2,633,082 | [1] | |||
| Weighted- Average Grant Date Fair Value per share, Beginning Balance | $ 0.46 | [1] | |||
| Number of Shares, Vested early-exercised stock option | (583,332) | (2,633,082) | [1] | ||
| Weighted- Average Grant Date Fair Value per share, Vested early-exercised stock option | $ 0.65 | $ 0.46 | [1] | ||
| Number of Shares, Ending Balance | 3,016,668 | ||||
| Weighted- Average Grant Date Fair Value per share, Ending Balance | $ 0.65 | ||||
| Number of Shares, Granted- 2023 Plan stock option | 3,600,000 | ||||
| Weighted- Average Grant Date Fair Value per share, Granted- 2023 Plan stock option | $ 0.65 | ||||
| |||||
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|